Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
—
Political receipts
—
Lobbying income
—
Lobbying expense
—
Federal awards
—
Relationships
20
| insider of | Inc. Aveo Pharmaceuticals | 18,897,312.21 | Jun 27, 2018 – Oct 19, 2022 |
| insider of | Regulus Therapeutics Inc. | 16,670,039.64 | May 7, 2019 – Dec 4, 2020 |
| insider of | SpyGlass Pharma, Inc. | 15,000,000 | Feb 9, 2026 – Feb 9, 2026 |
| insider of | Nkarta, Inc. | 11,999,988 | Jul 14, 2020 – Jul 14, 2020 |
| insider of | Metacrine, Inc. | 10,493,898.52 | Sep 18, 2020 – Dec 22, 2021 |
| insider of | Marker Therapeutics, Inc. | 9,999,998.75 | Mar 16, 2021 – Mar 16, 2021 |
| insider of | Akouos, Inc. | 9,999,995 | Jun 30, 2020 – Nov 30, 2022 |
| insider of | MBX Biosciences, Inc. | 8,000,000 | Sep 16, 2024 – Sep 16, 2024 |
| insider of | Inc. Mirum Pharmaceuticals | 6,750,000 | Jul 22, 2019 – Jun 13, 2023 |
| insider of | Korro Bio, Inc. | 5,999,991.95 | Apr 22, 2024 – Mar 10, 2026 |
| insider of | Eargo, Inc. | 5,609,170.03 | Oct 20, 2020 – May 25, 2021 |
| insider of | Inozyme Pharma, Inc. | 4,000,000 | Jul 25, 2020 – Jul 28, 2020 |
| insider of | Ardelyx Inc | 2,500,000 | Dec 9, 2019 – Dec 9, 2019 |
| insider of | Savara Inc. | 999,999 | Jul 17, 2023 – Jul 17, 2023 |
| insider of | Arcellx, Inc. | 5,502.46 | Dec 20, 2022 – Dec 21, 2022 |